In this episode of the Tacos & Tech Podcast, host Neal Bloom sits down with Jared Tangney, co-founder and CTO of Biolinq. From their early EvoNexus days to today’s FDA clearance, Jared walks us through the incredible journey of Biolinq - how it pivoted from sweat-sensing tattoos to a revolutionary microneedle platform that can measure glucose, lactate, and even cortisol with no blood and no pain.
Jared shares how a Mailchimp newsletter led to their first investor, Mark Cuban, and why he believes San Diego is the global epicenter for biosensing innovation. With a focus on serving the largest segment of the diabetes population and plans to expand into broader metabolic and stress biomarkers, Biolinq is changing what’s possible in wearable health tech.
Key Topics Covered:
* How Biolinq’s microneedle platform works and why it matters
* From sweat-based sensors to skin-based semiconductors
* Lessons from nearly a decade of R&D and pivots
* Measuring glucose, lactate, and now cortisol - what’s next?
* How a newsletter sign-up brought Mark Cuban in as the first investor
* Navigating FDA clearance and commercialization strategies
* San Diego’s competitive edge in biosensing, diabetes tech, and medical wearables
* The growing importance of AI and multi-analyte sensing in personal health
* Reflections on community, startup persistence, and tacos (Fish 101 for the win)
Links & Resources:Learn more about Biolinq
Connect with Jared Tangney:LinkedIn
